MicroRNAs that target Ca 2+ transporters are involved in vascular smooth muscle cell calcification

Laboratory Investigation

Volumn 92, Issue 9, 2012, Pages 1250-1259

  Gui, Ting ^a   Zhou, Gengyin ^b   Sun, Yujing ^a   Shimokado, Aiko ^a   Itoh, Shunji ^a   Oikawa, Kosuke ^a   Muragaki, Yasuteru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Shandong Provincial Key Laboratory of Mental Disorders   (China)

Author keywords

calcium channels; hyperphosphatemia; klotho; microRNA; vascular calcification

Indexed keywords

CALCIUM; CARRIER PROTEIN; KLOTHO PROTEIN; MICRORNA; MICRORNA 135A; MICRORNA 712; MICRORNA 714; MICRORNA 762; PHOSPHATE; PLASMA MEMBRANE CALCIUM PUMP ISOFORM 1 PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM POTASSIUM CALCIUM EXCHANGE MEMBER PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HOMOZYGOTE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; AORTA; BLOTTING, WESTERN; CALCINOSIS; CALCIUM; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; MEMBRANE TRANSPORT PROTEINS; MICE; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PHOSPHATES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84865639209     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.85     Document Type: Article

References (28)

1. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-1740. (Pubitemid 37098542)
2. Shroff R, Shanahan CM. Klotho: an elixir of youth for the vasculature? J Am Soc Nephrol 2011;22:5-7.
3. Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997;390:45-51. (Pubitemid 27494749)
4. Razzaque MS, Sitara D, Taguchi T, et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006;20:720-722. (Pubitemid 46671193)
5. Shimada T, Hasegawa H, Yamazaki Y, et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004;19:429-435. (Pubitemid 38787398)
6. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatric nephrology (Berlin, Germany) 2010;25:583-590.
7. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218. (Pubitemid 39031360)
8. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-2867. (Pubitemid 41103395)
9. Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 2005;310: 1817-1821. (Pubitemid 41814382)
10. Ambros V. The functions of animal microRNAs. Nature 2004;431: 350-355. (Pubitemid 39265675)
11. Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588. (Pubitemid 46897261)
12. Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-166.
13. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005;132:4653-4662. (Pubitemid 41685276)
14. Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res 2007;101:1225-1236. (Pubitemid 350294639)
15. Liu X, Cheng Y, Zhang S. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487.
16. Shroff RC, McNair R, Skepper JN, et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010;21:103-112.
17. Zeadin M, Butcher M, Werstuck G, et al. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2009;29:2069-2075.
18. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-E17.
19. Ola R, Jakobson M, Kvist J, et al. The GDNF target Vsnl1 marks the ureteric tip. J Am Soc Nephrol 2011;22:274-284.
20. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607-617.
21. Guo H, Ingolia NT, Weissman JS, et al. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010;466:835-840.
22. Hilgemann DW. New insights into the molecular and cellular workings of the cardiac Na+/Ca2+ exchanger. Am J Physiol Cell Physiol 2004;287:C1167-C1172. (Pubitemid 39382874)
23. Gros R, Afroze T, You XM, et al. Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ Res 2003;93:614-621. (Pubitemid 37222157)
24. Dong H, Jiang Y, Triggle CR, et al. Novel role for K+-dependent Na+/Ca2+ exchangers in regulation of cytoplasmic free Ca2+ and contractility in arterial smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H1226-H1235. (Pubitemid 44343667)
25. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 1999;79:763-854. (Pubitemid 29330173)
26. Fleckenstein-Grun G, Thimm F, Czirfuzs A, et al. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. J Cardiovasc Pharmacol 1994;24(Suppl 2): S75-S84. (Pubitemid 24369888)
27. Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001;37:1410-1413. (Pubitemid 34225383)
28. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2:ra81.